0001818382-23-000130.txt : 20230915 0001818382-23-000130.hdr.sgml : 20230915 20230915160618 ACCESSION NUMBER: 0001818382-23-000130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230914 FILED AS OF DATE: 20230915 DATE AS OF CHANGE: 20230915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Niklason Laura E CENTRAL INDEX KEY: 0001878075 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39532 FILM NUMBER: 231258739 MAIL ADDRESS: STREET 1: 35 WILSHIRE ROAD CITY: GREENWICH STATE: CT ZIP: 06831 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Humacyte, Inc. CENTRAL INDEX KEY: 0001818382 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851763759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-313-9633 MAIL ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20200716 4 1 wf-form4_169480836158057.xml FORM 4 X0508 4 2023-09-14 0 0001818382 Humacyte, Inc. HUMA 0001878075 Niklason Laura E 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 1 1 0 0 President, CEO and Director 0 Common Stock 2023-09-14 4 S 0 2000000 2.78 D 6191140 I By Ayabudge LLC Common Stock 1270240 D Common Stock 510161 I By spouse The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Dr. Niklason is treated as indirectly beneficially owning the shares sold, resulting in the requirement to file this Form 4. However, no shares directly beneficially owned by Dr. Niklason were sold in these transactions. /s/ Laura E. Niklason by Dale A. Sander as Attorney-in-Fact 2023-09-15